Cell line · CVCL_1270
HCC70
Cancer cell line, Homo sapiens. Breast ductal carcinoma. 69 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. HCC70. Cell lines, record CVCL_1270. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1270
On this page
Cell line
As Cellosaurus gives it.
- Name
- HCC70
- Accession
- CVCL_1270
- RRID
- RRID:CVCL_1270
- Synonyms
- HCC-70, HCC 70, HCC0070, Hamon Cancer Center 70
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 49Y
- Category
- Cancer cell line
- Diseases
- Breast ductal carcinoma (NCIt C4017)
- Derived from
- Breast (in situ)
- Cell type
- Epithelial cell of mammary gland
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers69
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HLA class I-specific nucleolin peptides induce therapeutic T cells in triple-negative breast cancer patients. | Int J Biol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mapping the Subtype-Specific PARP1 ADP-Ribosylated Proteome in Breast Cancer Cells. | Mol Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PFDN5 synergizes with anti-PD1 therapy to promote triple-negative breast cancer cell death through JAK2/STAT3/c-Myc signaling axis. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cyclin E modulates vulnerability to CDC7 kinase inhibition. | Oncogenesis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Discovery of novel circular RNAs of the apoptosis-related BAX gene in breast cancer, by combining nanopore and next-generation sequencing. | Mol Genet Genomics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Comparative theranostic efficacy of 177Lu- and 161Tb-labeled A1K2 SdAb in mesothelin-positive tumors. | Eur J Nucl Med Mol Imaging | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DS-3939a: A TA-MUC1-Directed Antibody-Drug Conjugate with Broad Antitumor Activity. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 69
See all 69 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Derived from it | HCC70/Cas9-hyg | CVCL_C9CI |
Source Cell lines
Cell banks4
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1270
GET https://conductscience.org/api/cell-lines/v1/CVCL_1270/papers?page=2